Stock Fundamentals

Company Information

Company Name
Ascendis Pharma AS
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US04351P1012
CIK: 0001612042
CUSIP: 04351P101
Currency: USD
Full Time Employees: 1,189
Phone: 45 70 22 22 44
Fiscal Year End: December
IPO Date: Jan 28, 2015
Description:

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

Address:

Tuborg Boulevard 12, Hellerup, Denmark, 2900

Directors & Officers

Name Title Year Born
Mr. Jan Moller Mikkelsen President, CEO, Member of Executive Board & Executive Director 1960
Mr. Scott T. Smith CFO, Executive VP & Member of Executive Board 1974
Ms. Pedersen Anni Lotte Kirstine Sonderbjerg Executive VP, Chief Administrative Officer & Member of the Executive Board 1961
Mr. Michael Wolff Jensen L.L.M. Executive VP, Chief Legal Officer & Member of the Executive Board 1971
Mr. Mads Bodenhoff Senior VP, Head of Finance & Principal Accounting Officer 1970
Mr. Chad Fugure Vice President of Investor Relations NA
Mr. Flemming Steen Jensen Executive Vice President of Product Supply & Quality 1961
Dr. Kennett Sprogoe Ph.D. Executive VP and Head of Research & Product Development 1979
Dr. Stina Singel M.D., Ph.D. Executive VP & Head of Clinical Development for Oncology 1974
Mr. Joseph Kelly Head of U.S. Commercial of Endocrinology 1969

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
RA Capital Management, LLC 10.28M Mar 31, 2026 16.75% $24.92 0.00%
venBio Select Advisor LLC 5.06M Mar 31, 2026 8.25% $11.39 -0.95%
Westfield Capital Management Company, L.P. 4.81M Mar 31, 2026 7.84% $4.62 -7.18%
FMR Inc 3.88M Mar 31, 2026 6.32% $0.05 -6.66%
Artisan Partners Limited Partnership 3.23M Mar 31, 2026 5.26% $1.19 0.13%
Franklin Resources Inc 2.05M Mar 31, 2026 3.34% $0.12 7.43%
Capital Research & Mgmt Co - Division 3 1.96M Mar 31, 2026 3.19% $0.11 -36.07%
Massachusetts Financial Services Company 1.86M Mar 31, 2026 3.03% $0.14 -1.36%
Wellington Management Company LLP 1.76M Mar 31, 2026 2.86% $0.08 -0.29%
Perceptive Advisors LLC 1.53M Mar 31, 2026 2.50% $6.84 41.61%
American Century Companies Inc 1.40M Mar 31, 2026 2.28% $0.16 -3.19%
Capital World Investors 900.52K Mar 31, 2026 1.47% $0.03 0.00%
Principal Financial Group Inc 896.40K Mar 31, 2026 1.46% $0.11 -12.67%
BlackRock Inc 661.05K Mar 31, 2026 1.08% $0.00 5.23%
Polar Capital Holdings PLC 651.71K Mar 31, 2026 1.06% $0.53 75.91%
Morgan Stanley - Brokerage Accounts 606.35K Mar 31, 2026 0.99% $0.01 -1.88%
The Goldman Sachs Group Inc 566.19K Mar 31, 2026 0.92% $0.01 -5.11%
Delaware Management Holdings Inc 556.43K Mar 31, 2026 0.91% $0.22 11.99%
JPMorgan Chase & Co 539.43K Mar 31, 2026 0.88% $0.01 6.35%
Ameriprise Financial Inc 476.47K Mar 31, 2026 0.78% $0.03 -13.44%

Shares Statistics

Shares Outstanding: 65.58M
Shares Float: 62.11M
% Insiders: 81.70%
% Institutions: 11,049.10%
Short % Float: 3.34%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 MFS Mid Cap Growth Equity 1.27M 2.08% ▼ 0.46% Mar 31, 2026
2 Capital Group Growth Fnd of Amer Comp 1.21M 1.97% ▲ 0.00% Mar 31, 2026
3 American Funds Growth Fund of Amer A 1.21M 1.97% ▲ 0.00% Mar 31, 2026
4 Vanguard Health Care Inv 1.10M 1.80% ▲ 0.00% Mar 31, 2026
5 Franklin Innovation Composite 1.10M 1.79% ▲ 10.00% Mar 31, 2026
6 Janus Henderson Mid Cap Growth MA 976.88K 1.59% ▲ 0.00% Sep 30, 2025
7 T. Rowe Price US Mid-Cap Growth Equity 783.40K 1.28% ▼ 0.09% Mar 31, 2026
8 Artisan Mid Cap Investor 678.34K 1.11% ▼ 3.80% Mar 31, 2026
9 Artisan U.S. Mid-Cap Growth 678.34K 1.11% ▼ 3.80% Mar 31, 2026
10 American Century US Premier Lg Cp Gr 664.00K 1.08% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $14.68B
Trailing P/E: 24.98
Forward P/E: 13.48

Financial Highlights

Market Cap: $14.30B
EBITDA: $-10.22M
P/E Ratio: $24.98
Book Value: $9.09
Earnings/Share: $8.73
Profit Margin: 57.28%
Operating Margin: 10.06%
ROA (TTM): -0.60%
ROE (TTM): 33.27%
Revenue (TTM): $865.78M
Revenue/Share (TTM): $14.19
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 144.30%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.04x -5.36x 1.12x -1.69x -7.94x
2024-12-31 1.17x -8.10x 1.09x -4.26x -2.95x
2023-12-31 0.95x -6.66x 1.18x -10.34x -2.36x
2022-12-31 1.29x 3.45x 0.76x -18.31x -1.72x
2021-12-31 8.03x 0.13x 0.19x -115.52x -0.31x
2020-12-31 14.02x 0.01x 0.14x -172.38x -0.02x
2019-12-31 12.74x 0.01x 0.12x -185.68x -0.03x
2018-12-31 7.53x 0.00x 0.12x -1,218.56x 0.00x
2017-12-31 8.61x 0.00x 0.11x -1,149.91x 0.00x
2016-12-31 13.67x 0.00x 0.07x -14,584.00x 0.00x
2015-12-31 10.98x 0.00x 0.09x -6,970.83x 0.00x
2014-12-31 4.13x 0.00x 0.22x -749.31x 0.00x
2013-12-31 1.04x 0.00x 0.76x 659.88x 0.00x
2012-12-31 0.87x 0.14x 0.94x 75.65x 0.12x
2011-12-31 0.80x 0.80x 0.99x N/A N/A

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ASND.US!